<DOC>
	<DOCNO>NCT00941018</DOCNO>
	<brief_summary>This study conduct determine safety , tolerability , pharmacodynamics pharmacokinetics RX-10001 .</brief_summary>
	<brief_title>Single Multiple Ascending Oral Dose Study RX-10001 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>BMI : 18 32 kg/m2 , inclusive Female subject : must nonchildbearing potential ( either surgically sterilize least 1 year postmenopausal ( amenorrhea duration 12 month ) Ability willingness abstain alcohol , methylxanthinecontaining beverage food ( coffee , tea , cola , chocolate , `` power drink '' ) grapefruit ( juice ) 48 h prior entry clinical research center discharge Medical history without major pathology Resting supine blood pressure pulse rate show clinically relevant deviation judge MI Computerised ( 12lead ) ECG record without sign clinically relevant pathology show clinically relevant deviation judge MI All value hematology clinical chemistry test blood urine within normal range show clinically relevant deviation judge MI Willingness sign write Informed Consent Form ( ICF ) Evidence clinically relevant pathology Mental handicap History relevant drug and/or food allergy Regular/routine treatment nontopical medication within 30 day prior drug administration Use tobacco product ( less 60 day prior drug administration ) History alcohol abuse drug addiction ( include soft drug like cannabis product ) Use concomitant medication ( include counter medication , health supplement , multivitamin vitamin C , vitamin omega3 supplement , herbal remedy St. John 's Wort extract ) must stop least 14 day prior first dose . The use limit amount acetaminophen ( paracetamol ) permit discretion MI . Participation drug study within 60 day prior drug administration . Participation 3 drug study 10 month precede start study . Donation 100 mL blood within 60 day prior drug administration . Donation 1.5 litre blood 10 month precede start study . Positive screen drug abuse ( opiate , methadone , cocaine , amphetamine , cannabinoids ) , barbiturates , benzodiazepine , tricyclic antidepressant alcohol Intake 24 unit alcohol per week ( one unit alcohol equal approximately 250 mL beer , 100 mL wine 35 mL spirit ) Positive screen HBsAg Positive screen anti HCV Positive screen anti HIV 1/2 Illness within 5 day prior ( first ) drug administration Exposure radiation diagnostic reason ( except dental Xrays plain Xrays thorax bony skeleton ( exclude spinal column ) ) , work participation medical trial previous year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Resolvins</keyword>
	<keyword>RvE1</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>